Cas:1215205-54-1 3-Methoxy-5-methylbiphenyl-3-carboxylic acid manufacturer & supplier

We serve Chemical Name:3-Methoxy-5-methylbiphenyl-3-carboxylic acid CAS:1215205-54-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Methoxy-5-methylbiphenyl-3-carboxylic acid

Chemical Name:3-Methoxy-5-methylbiphenyl-3-carboxylic acid
CAS.NO:1215205-54-1
Synonyms:3-(3-methoxy-5-methylphenyl)benzoic acid
Molecular Formula:C15H14O3
Molecular Weight:242.27000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.53000
Exact Mass:242.09400
LogP:3.36880

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(3-methoxy-5-methylphenyl)benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(3-methoxy-5-methylphenyl)benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(3-methoxy-5-methylphenyl)benzoic acid Use and application,3-(3-methoxy-5-methylphenyl)benzoic acid technical grade,usp/ep/jp grade.


Related News: With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. N,N-DiBoc-4-amino-6-chloropyrimidine manufacturers GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. caps suppliers With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. 3-P-Tolylpropenal vendor & factory The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said.,It is always advisable for companies to start the clinical study responsibilities early on to combat unforeseen challenges that require more time.